Menu Search
Equities

Craneware PLC

3X6:STU

Craneware PLC

Actions
  • Price (EUR)26.00
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change+43.65%
  • Beta--
Data delayed at least 15 minutes, as of Nov 21 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Craneware plc is a United Kingdom company that is engaged in the development, licensing and ongoing support of computer software for the United States healthcare industry. The Company is engaged in automated value cycle solutions, including 340B management, collaborates with United States healthcare providers to plan, execute, and monitor operational and financial performance, so they can deliver quality care to their communities. The Company combines revenue integrity, cost management, 340B performance, and decision enablement into a single, software-as-a-service (SaaS)-based platform. Its solutions include Trisus Pricing Transparency, Trisus Pricing Analyzer, Trisus Chargemaster, Insight Medical Necessity, Trisus Claims Informatics, Trisus Supply, Appeals Services, Trisus Supplies Assistant, Trisus Medication Analytic Solutions, Sentinel, Sentrex, Referral Verification System, Trisus Medication Formulary, Trisus Medication Financial Management, InSight Audit and others.

  • Revenue in GBP (TTM)149.62m
  • Net income in GBP9.25m
  • Incorporated1999
  • Employees747.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.